73 In the index

Afobazole AFOB

An anti-anxiety medication developed and used in Russia that works differently from typical anxiety drugs and isn't thought to be habit-forming. Russian studies support that it reduces anxiety, but it hasn't been approved or independently tested in the U.S. or Europe.

Also known as Fabomotizole

Effects Mood

Routes Oral

Legal status Unapproved / investigational

WADA Not listed

3D Molecular Structure of C₁₅H₂₁N₃O₂S

Drag to rotate · scroll to zoom

Chemistry

Formula: C15H21N3O2S
Molar mass: 307.4
CAS: 173352-21-1
PubChem CID: 9862937

Reported dosing

Limited data

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose 10 mg per dose

Reported range 10-60 mg/day

Route Oral

Frequency Three times daily

Duration 2-4 week course (as used in Russia)

Approved and sold over-the-counter in Russia; not FDA-approved or available by prescription in the US.

Where this comes from Russian-language clinical studies

Human data for this compound is limited. Read the figures above as a record of reported use rather than established dosing.